newsfilter
← Latest News
Business Wire·

Verastem Oncology Announces Planned Chief Executive Officer Transition and Succession Plan

Accomplished biopharmaceutical executive Michael P. Bailey appointed President and CEO to advance Verastem’s commercial business and lead pipeline asset advancement for VS-7375, a potential best-in-class